Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease
- PMID: 10029385
- DOI: 10.1080/110241598750005066
Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease
Similar articles
-
Mesalamine derivatives in the treatment of Crohn's disease.Gastroenterol Clin North Am. 2004 Jun;33(2):303-17, ix-x. doi: 10.1016/j.gtc.2004.02.010. Gastroenterol Clin North Am. 2004. PMID: 15177540 Review.
-
Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?Rev Gastroenterol Disord. 2002;2 Suppl 2:S9-15. Rev Gastroenterol Disord. 2002. PMID: 12478239 Review.
-
Controversies with aminosalicylates in inflammatory bowel disease.Rev Gastroenterol Disord. 2004 Summer;4(3):104-17. Rev Gastroenterol Disord. 2004. PMID: 15359211 Review.
-
Drug insight: aminosalicylates for the treatment of IBD.Nat Clin Pract Gastroenterol Hepatol. 2007 Mar;4(3):160-70. doi: 10.1038/ncpgasthep0696. Nat Clin Pract Gastroenterol Hepatol. 2007. PMID: 17339853 Review.
-
Medical therapy to reduce postoperative Crohn's disease recurrence.Am J Gastroenterol. 2000 May;95(5):1139-46. doi: 10.1111/j.1572-0241.2000.02000.x. Am J Gastroenterol. 2000. PMID: 10811318 Review.
Cited by
-
Traditional corticosteroids for induction of remission in Crohn's disease.Cochrane Database Syst Rev. 2008 Apr 16;2008(2):CD006792. doi: 10.1002/14651858.CD006792.pub2. Cochrane Database Syst Rev. 2008. PMID: 18425970 Free PMC article.
-
Cost of illness of Crohn's disease.Pharmacoeconomics. 2002;20(10):639-52. doi: 10.2165/00019053-200220100-00001. Pharmacoeconomics. 2002. PMID: 12162753 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical